Clinical trial
AMEVIVE® Pregnancy Registry
NCT00342862 · Astellas Pharma Inc, Industry · Terminated
Key facts
| NCT number | NCT00342862 |
|---|---|
| Title | AMEVIVE® Pregnancy Registry |
| Official title | Assessment and Tracking of Long-Term Alefacept (LFA-3/IgG1 Fusion Protein) Pregnancy Exposure Registry |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Pregnancy |
| Intervention type | Drug |
| Interventions | Amevive exposure |
| Enrollment | 3 |
| Start date | Dec 1, 2003 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Jun 21, 2006 |
| Last update posted | Dec 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: